NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

The National Institute of Dental and Craniofacial Research (NIDCR) is seeking applications to plan and implement clinical trials for drug, biologic, device, and/or procedure interventions. The award will be made as a cooperative agreement, and the project will be divided into two phases: UG3 and UH3. The UG3 phase will focus on planning and developing the clinical trial, while the UH3 phase will involve the implementation of the trial. • The clinical trial must be within the mission of the NIDCR. • The trial must be a clinical trial required for UG3/UH3 phased cooperative agreements. • The applicant must provide a detailed plan for the clinical trial, including the study design, sample size, and outcome measures. • The applicant must also provide a detailed budget and timeline for the project. • The award will be made for a period of up to 5 years, with the possibility of renewal. • The applicant must demonstrate experience and expertise in conducting clinical trials. • The applicant must also demonstrate a strong commitment to diversity and inclusion in the conduct of the clinical trial.